RBC
AXGN icon

Roble Belko & Company’s Axogen AXGN Stock Holding History

Roble Belko & Company’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100
Closed -$1K – 268
2016
Q1 		$1K Hold
100
– – ﹤0.01% 250
2015
Q4 		$1K Hold
100
– – ﹤0.01% 207
2015
Q3 		$0 Sell
100
-200
-67% -$801 ﹤0.01% 208
2015
Q2 		$1K Hold
300
– – ﹤0.01% 224
2015
Q1 		$1K Buy
+300
New +$1.03K ﹤0.01% 229

Other funds holding AXGN

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Roble Belko & Company's AXGN Position: Q2 2016 in Review

Roble Belko & Company sold out of Axogen (AXGN) in Q2 2016, closing a stake of 100 shares — an estimated $1K sold.

Roble Belko & Company first reported a position in AXGN in Q1 2015 and held it in 5 quarters. The position peaked at $1K in Q1 2016. 67 funds tracked by Wall St. Rank hold AXGN as of Q2 2016.

  • Roble Belko & Company reported no remaining Axogen position as of Q2 2016 after selling out during the quarter.
  • Roble Belko & Company sold 100 Axogen shares in Q2 2016, an estimated $1K.
  • Roble Belko & Company first reported a position in Axogen in Q1 2015 and held it in 5 quarters.
  • Roble Belko & Company's Axogen position peaked at $1K in Q1 2016.
  • 67 funds tracked by Wall St. Rank held Axogen as of Q2 2016.

Based on Roble Belko & Company's 13F filing for Q2 2016, filed 11 Aug 2016.